Clinical Trials Directory

Trials / Unknown

UnknownNCT02265315

Augmenting Treatment Effects of Voice Therapy in Parkinson Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Le Bonheur Children's Hospital · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the impact of a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) on voice/speech treatment in people with Parkinson's Disease (PD), through the use of speech and voice analysis, examination of voice box, and brain imaging methods.

Detailed description

Effective treatment of the speech disorder in IPD is as important as the optimal control of limb motor symptoms. Presently, the Lee Silverman Voice Treatment (LSVTÒ LOUD) - is a time intensive behavioral treatment for Parkinson's hypophonia. Facilitatory TMS is a safe and a complimentary stimulation technique. Brain imaging has also identified suitable target brain regions that are readily accessible to TMS. This combined treatment modality approach should be more effective and efficient the LSVT alone. The study will enroll patients with Parkinson's disease with moderate to severe hypophonia. A total of 36 patients will be recruited over 3 years and divided into 3 groups (n=12 each). The three cohorts are: 1. LSVT +sham TMS; 2. LSVT +left rTMS and 3. LSVT + right rTMS. This is a longitudinal double blind randomized controlled clinical trial. All investigators and study personnel will be blind to the study except for the PI responsible for TMS (Dr. Narayana). The entire protocol occurs over 19 weeks. During the first week, the participants will be screened, consented. During the second week, baseline behavioral and imaging data will be collected. Next, the patients will be randomized to one of the three treatment groups. Then the patients will enter a 4-week treatment phase, where they will receive TMS/sham TMS and LSVT 4 days a week for 4 weeks. During the seventh week, patients will undergo post treatment behavioral and imaging assessments. Then the patients will return in week 19 to complete the follow up behavioral measures and imaging session.

Conditions

Interventions

TypeNameDescription
OTHERTranscranial Magnetic StimulationTreament adjuvant applied to accelerate vocal motor learning and overall voice improvement
BEHAVIORALLee Silverman Voice TreatmentTime intensive behavioral treatment for Parkinson's hypophonia

Timeline

Start date
2014-10-01
Primary completion
2020-12-31
Completion
2021-06-30
First posted
2014-10-15
Last updated
2020-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02265315. Inclusion in this directory is not an endorsement.